List of Excipients in API GANAXOLONE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing GANAXOLONE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Marinus Pharmaceuticals Inc | ZTALMY | ganaxolone | 81583-100 | ANHYDROUS CITRIC ACID | 2029-06-01 |
| Marinus Pharmaceuticals Inc | ZTALMY | ganaxolone | 81583-100 | HYPROMELLOSE | 2029-06-01 |
| Marinus Pharmaceuticals Inc | ZTALMY | ganaxolone | 81583-100 | METHYLPARABEN | 2029-06-01 |
| Marinus Pharmaceuticals Inc | ZTALMY | ganaxolone | 81583-100 | POLYVINYL ALCOHOL | 2029-06-01 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for GANAXOLONE
Excipient focus: ANHYDROUS CITRIC ACID
GANAXOLONE drug variants containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Marinus Pharmaceuticals Inc | ganaxolone | 81583-100 |
| >Company | >Ingredient | >NDC |
GANAXOLONE drug variants not containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
GANAXOLONE drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Marinus Pharmaceuticals Inc | ganaxolone | 81583-100 |
| >Company | >Ingredient | >NDC |
GANAXOLONE drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
GANAXOLONE drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Marinus Pharmaceuticals Inc | ganaxolone | 81583-100 |
| >Company | >Ingredient | >NDC |
GANAXOLONE drug variants not containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
GANAXOLONE drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Marinus Pharmaceuticals Inc | ganaxolone | 81583-100 |
| >Company | >Ingredient | >NDC |
GANAXOLONE drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLPARABEN
GANAXOLONE drug variants containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Marinus Pharmaceuticals Inc | ganaxolone | 81583-100 |
| >Company | >Ingredient | >NDC |
GANAXOLONE drug variants not containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM BENZOATE
GANAXOLONE drug variants containing SODIUM BENZOATE
| Company | Ingredient | NDC |
|---|---|---|
| Marinus Pharmaceuticals Inc | ganaxolone | 81583-100 |
| >Company | >Ingredient | >NDC |
GANAXOLONE drug variants not containing SODIUM BENZOATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CITRATE
GANAXOLONE drug variants containing SODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Marinus Pharmaceuticals Inc | ganaxolone | 81583-100 |
| >Company | >Ingredient | >NDC |
GANAXOLONE drug variants not containing SODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
GANAXOLONE drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Marinus Pharmaceuticals Inc | ganaxolone | 81583-100 |
| >Company | >Ingredient | >NDC |
GANAXOLONE drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SUCRALOSE
GANAXOLONE drug variants containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| Marinus Pharmaceuticals Inc | ganaxolone | 81583-100 |
| >Company | >Ingredient | >NDC |
GANAXOLONE drug variants not containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
GANAXOLONE drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Marinus Pharmaceuticals Inc | ganaxolone | 81583-100 |
| >Company | >Ingredient | >NDC |
GANAXOLONE drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
